KEELY HOOKS: Open Payments
NPI 1912305269 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 95 payments from 22 companies in 2025. Trend: 2023 $1,274 · 2024 $1,886 · 2025 $1,781
Food & beverage: $1,781
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $209 |
| Lilly USA, LLC | 10 | $192 |
| Amgen Inc. | 15 | $175 |
| Novo Nordisk Inc | 10 | $169 |
| AstraZeneca Pharmaceuticals LP | 8 | $165 |
| GlaxoSmithKline, LLC. | 7 | $151 |
| Abbott Laboratories | 4 | $94 |
| PFIZER INC. | 4 | $89 |
| SHIELD THERAPEUTICS INC | 4 | $78 |
| ABBVIE INC. | 3 | $50 |
Products named: Kerendia, TRELEGY ELLIPTA, OTEZLA, AIRSUPRA, MOUNJARO, FREESTYLE LIBRE 3, JARDIANCE, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
